Coronavirus disease 2019 (COVID-19) is caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It is known that host
microRNAs (
miRNAs) can be modulated to favor
viral infection or to protect the host. Herein, we report preliminary results of a study aiming at identifying differentially expressed plasmatic
miRNAs in Brazilian patients with
COVID-19.
METHODS AND RESULTS:
miRNAs were extracted from the plasma of eight patients with
COVID-19 (four patients with mild
COVID-19 and four patients with severe/critical
COVID-19) and four healthy controls. Patients and controls were matched for sex and age.
miRNA expression levels were detected using high-throughput sequencing. Differential
miRNA expression and enrichment analyses were further evaluated. A total of 18
miRNAs were differentially expressed between patients with
COVID-19 and controls. miR-4433b-5p, miR-6780b-3p, miR-6883-3p, miR-320b, miR-7111-3p, miR-4755-3p, miR-320c, and miR-6511a-3p were the most important
miRNAs significantly involved in the PI3K/AKT, Wnt/β-
catenin, and STAT3 signaling pathways. Moreover, 42
miRNAs were differentially expressed between severe/critical and mild patients with
COVID-19. miR-451a, miR-101-3p, miR-185-5p, miR-30d-5p, miR-25-3p, miR-342-3p, miR-30e-5p, miR-150-5p, miR-15b-5p, and miR-29c-3p were the most important
miRNAs significantly involved in the Wnt/β-
catenin, NF-κβ, and STAT3 signaling pathways.
CONCLUSIONS: If validated by quantitative real-time
reverse transcriptase-polymerase chain reaction (RT-PCR) in a larger number of participants, the
miRNAs identified in this study might be used as possible
biomarkers for the diagnosis and severity of
COVID-19.